🇺🇸 FDA
Patent

US 9933434

Therapeutic antibodies against ROR-1 protein and methods for use of same

granted A61KA61K2039/505A61P

Quick answer

US patent 9933434 (Therapeutic antibodies against ROR-1 protein and methods for use of same) held by The Regents of the University of California expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/505, A61P, A61P35/00, A61P35/02